Vi bruger cookies på accura.dk

accura.dk anvender cookies for at forbedre brugervenligheden og funktionaliteten. Når du benytter sitet, samtykker du til vores anvendelse af cookies. Læs mere om cookies på accura.dk. God fornøjelse.

Læs mere om vores cookie-politik og få vejledning til at slette cookies

Print Tip en ven LinkedIn

IPR & Life Science Newsletter

March 2018: An overview of the Danish government’s brand new Life Science Growth Plan, and important news on confidentiality between patent attorneys and their clients. Open newsletter.

February 2018: A broad range of topics, from a controversial new pilot programme on medicinal cannabis over key European case law on both transparency of clinical data and fraudulent trademark invoices, the Danish court system going fully digital, and important new guidelines significantly altering how to offer professionally relevant courses and congresses to Danish healthcare professionals. Open newsletter.

January 2018: How IoT and the UPC bring about significant new developments in European patent law, and new Danish rules on OTC pharma. Open newsletter.

November 2017: The important provisional measures such as preliminary injunctions before the UPC, Accura's practical Quick guide to proper use of trademarks and information on the Danish Medicines Council's newly adopted and faster process for assessment of medicinal products without added clinical value. Open newsletter.

October 2017: The procedures of litigation before the UPC, information on the improved options for registering motion marks and news on Thailand’s accession to the Madrid Protocol. Open newsletter.

August 2017: The Unified Patent Court and Guide on Pre-Launch of Medicines. Open newsletter.